Post-conditioning to Reduce Infarct Size

Sponsor
Minneapolis Heart Institute Foundation (Other)
Overall Status
Completed
CT.gov ID
NCT00755469
Collaborator
Society for Cardiovascular Angiography and Interventions (Other)
43
1
1
23
1.9

Study Details

Study Description

Brief Summary

When angioplasty (PTCA) and stenting of the blood vessels of the heart is the treatment for a Heart Attack, there is damage to the heart muscle that is caused by the sudden opening of the blood vessels. This is called "reperfusion injury". The cell death is due to inflammation and the generation of free radicals.

The primary objective of this study is to determine if post-conditioning(four brief (30 second) PTCA balloon inflations) reduces damage to the heart muscle. This will be measured by heart enzyme tests-CK measurements- and by cardiac MRI.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Post-conditioning
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
43 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Modification of Reperfusion by "Post-Conditioning" Reduces Infarct Size in Acute Myocardial Infarction
Study Start Date :
Sep 1, 2008
Actual Primary Completion Date :
Aug 1, 2010
Actual Study Completion Date :
Aug 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Procedure: Post-conditioning
The post-conditioning protocol consists of performing 4, 30-second PTCA balloon occlusions followed by 30 seconds of reperfusion for a total of 4 minutes. The first balloon inflation occurs immediately after an angioplasty guidewire is placed through the obstruction in the artery and flow is restored. Following this protocol the vessel will be stented as part of usual practice for treatment of acute MI.

Outcome Measures

Primary Outcome Measures

  1. Infarct size, determined by late-enhancement measurements of the LV using gadolinium contrast with cardiac MRI [3 months]

Secondary Outcome Measures

  1. The degree of Microvascular Obstruction (MVO), as measured by Cardiac MRI [3 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18 < 80

  • Able to give informed consent

  • 100% occlusion of a major epicardial vessel with TIMI 0 Flow

Exclusion Criteria:
  • Significant collateral blood flow to the distal vasculature of the occluded vessel.

  • Previous CABG

  • Previous q-wave myocardial infarction in the same territory

Contacts and Locations

Locations

Site City State Country Postal Code
1 Abbott Northwestern Hospital Minneapolis Minnesota United States 55407

Sponsors and Collaborators

  • Minneapolis Heart Institute Foundation
  • Society for Cardiovascular Angiography and Interventions

Investigators

  • Principal Investigator: Jay H Traverse, MD, Minneapolis Heart Institute at Abbott Northwestern Hospital

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Minneapolis Heart Institute Foundation
ClinicalTrials.gov Identifier:
NCT00755469
Other Study ID Numbers:
  • opt002
First Posted:
Sep 19, 2008
Last Update Posted:
Dec 5, 2013
Last Verified:
Dec 1, 2013
Keywords provided by Minneapolis Heart Institute Foundation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 5, 2013